Early brain monitoring and oxygen levels to predict outcomes in newborns with mild HIE
Official title: Predictive Value of Amplitude-Integrated Electroencephalography and Cerebral Tissue Oxygenation on Neurological Outcomes in Neonates With Mild Hypoxic-Ischemic Encephalopathy
Run by Uludag University · NCT07393620 · Data updated 2026-11-12
This project will try to see if early aEEG monitoring and measurements of cerebral oxygen levels can predict later neurological outcomes in newborns with mild hypoxic‑ischemic encephalopathy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Hours to 6 Hours |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Uludag University Academic / other |
| Locations | 3 sites (Bursa and 2 other locations) |
| Status | Recruiting |
| Started | February 10, 2026 |
| Main results expected | February 10, 2027 |
| Study ends | February 10, 2029 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT07393620 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Term or near‑term newborns (≥36 weeks) enrolled within 6 hours of birth with blood gas and clinical criteria consistent with perinatal asphyxia and classified as having mild HIE are the ideal candidates.
✕Probably not a fit
Preterm infants under 36 weeks, infants presenting after the 6‑hour window, or those with clear moderate to severe HIE (who already receive therapeutic hypothermia) are unlikely to benefit from this observational monitoring protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study of term and near‑term newborns with mild hypoxic‑ischemic encephalopathy who are enrolled within the first 6 hours after birth. Infants will undergo routine clinical monitoring with amplitude‑integrated EEG (aEEG) and near‑infrared spectroscopy (NIRS) cerebral oxygenation measurements during the first 72 hours of life. Neurological examinations and developmental follow‑up will be performed in early infancy and at later visits to record outcomes. The study aims to link early physiologic monitoring patterns with subsequent neurodevelopment to improve early risk stratification.
Why it matters
Potential benefit: If successful, this approach could help identify newborns with mild HIE who are at higher risk for later neurological problems so they can get closer monitoring or earlier interventions.
How similar studies have gone: Prior work in moderate and severe HIE has shown that aEEG and NIRS patterns can correlate with outcomes and provide promising signals, but evidence specifically guiding management of mild HIE remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Gestational age and postnatal age:
Gestational age ≥ 36 0/7 weeks and enrollment within the first 6 hours after birth.
2. Blood gas criteria
Umbilical cord or postnatal (≤ 1 hour of life) blood gas showing:
1. pH ≤ 7.00 or base deficit ≥ 16 mmol/L
2. OR, if pH is 7.01-7.15 or base deficit is 10-15.9 mmol/L, the presence of both:
* An acute perinatal event, and
* Apgar score ≤ 5 at 10 minutes or ongoing resuscitation at 10 minutes of life, including the need for positive pressure ventilation.
( Evidence of an acute peripartum and intrapartum asphyxia event, defined by at least one of the following: Uterine rupture, placental abruption, umbilical cord prolapse, rupture, tight nuchal cord, maternal hemorrhage, trauma, or cardiopulmonary arrest, vasa previa, category III fetal heart rate tracing, including having either a sinusoidal pattern or absent baseline variability plus recurrent late decelerations, recurrent variable decelerations, or bradycardia.)
3. Clinical evidence of encephalopathy Findings consistent with Sarnat and Sarnat Stage 1 (mild) encephalopathy. Mild, moderate, or severe abnormalities may be present in at least one of the six categories (level of consciousness, spontaneous activity, posture, tone, primitive reflexes \[suck and Moro\], autonomic nervous system), provided that no more than two categories show moderate or severe findings.
Exclusion Criteria:
Newborns meeting any of the following criteria will be excluded from the study:
1. Normal neurological examination Newborns with a completely normal neurological examination according to Sarnat and Sarnat staging.
2. Moderate or severe encephalopathy within the first 6 hours of life
1. Clinical findings consistent with moderate or severe encephalopathy during the first 6 hours after birth.
2. Presence of clinical seizures.
3. aEEG findings consistent with moderate or severe encephalopathy requiring therapeutic hypothermia.
4. Evidence of electrographic seizure activity on aEEG monitoring.
3. Sarnat and Sarnat criteria for moderate-severe encephalopathy Findings consistent with moderate or severe encephalopathy in three or more Sarnat categories, classified as moderate or severe hypoxic-ischemic encephalopathy.
4. Contraindications to therapeutic hypothermia, including:
* Evaluation occurring more than 6 hours after birth.
* Gestational age \< 36 weeks or birth weight \< 2000 g.
* Severe or extensive intracranial parenchymal hemorrhage.
* Severe, life-threatening coagulopathy.
* Intracerebral infarction.
* Chromosomal abnormalities (e.g., trisomy 13 or 18) or major congenital anomalies involving multiple organ systems.
5. Lack of parental informed consent
6. Cyanotic congenital heart disease
7. Metabolic encephalopathy Encephalopathy due to metabolic disorders not related to hypoxic-ischemic events.
8. Other conditions associated with encephalopathy unrelated to acute hypoxia
* Abnormal fetal growth.
* Maternal infections.
* Fetomaternal hemorrhage.
* Severe neonatal sepsis.
* Chronic placental lesions.
Where it's running
-
Bursa City Hospital
Bursa, Turkey (Türkiye) Recruiting -
Division of Neonatology, Department of Pediatrics, Bursa Uludağ University Faculty of Medicine
Bursa, Turkey (Türkiye) Recruiting -
Division of Neonatology, Department of Pediatrics, University of Health Sciences Bursa Yuksek İhtisas Training and Research Hospital
Bursa, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Salih Çağrı Çakır
- Email: salihcagri@uludag.edu.tr
- Phone: +90 533 3453739
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing therapies for infants with mild brain injury
This study is testing whether cooling therapy can help infants with mild brain injury do better in their development compared to regular body temperature treatment.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Neonatal Neurological Observation With Video AI
This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Genome sequencing for newborns with perinatal hypoxic‑ischemic encephalopathy
This program will try genome sequencing for newborns with moderate-to-severe hypoxic‑ischemic encephalopathy who are receiving therapeutic cooling, using parent samples to help interpret results.
-
Understanding how different anesthetics affect brain blood flow and oxygen levels during MRI
This study is testing how different types of anesthesia affect blood flow and oxygen levels in the brain during MRI scans in kids and teens.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.